Ashish Sarraju, MD, discusses phase 1 data showing a single dose of Kylo-11 durably reduced lipoprotein(a) through 48 weeks.
Ashish Sarraju, MD
Advertisement
Ashish Sarraju, MD, is a cardiologist in the Heart, Vascular & Thoracic Institute at Cleveland Clinic.
Articles by Ashish Sarraju, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
ESC Congress 2026: Day 1 Recap—5 Headlines to Know
2
Sex Hormones, Aldosterone, and Hypertension Risk in Women, With Erin Michos, MD
3
ENRICH-AF: Edoxaban Increases Bleeding Without Reducing Stroke
4
STAREE: Statins Reduce Cardiovascular Events But Not Disability in Older Adults
5